CLINICAL_TRIALS
trial_result
· 2012-10-15
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of BRL 49653C in Non-insulin Dependent Diabetes [Phase 3]
Summary
Phase 3 study evaluating BRL 49653C for type 2 diabetes mellitus has completed, assessing its efficacy and safety.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Taiwan University Hospital | Conditions: Diabetes Mellitus Non Insulin Dependent Oral Agent Therapy | Phase 3 | Status: COMPLETED